Bridges Investment Counsel Inc. cut its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 36.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,493 shares of the pharmacy operator’s stock after selling 2,557 shares during the period. Bridges Investment Counsel Inc.’s holdings in Walgreens Boots Alliance were worth $373,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Price T Rowe Associates Inc. MD increased its stake in shares of Walgreens Boots Alliance by 35.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 39,319,406 shares of the pharmacy operator’s stock worth $3,169,931,000 after buying an additional 10,206,621 shares during the last quarter. Norges Bank bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $649,813,000. Nordea Investment Management AB boosted its stake in Walgreens Boots Alliance by 4,480.8% in the third quarter. Nordea Investment Management AB now owns 7,453,892 shares of the pharmacy operator’s stock valued at $600,933,000 after buying an additional 7,291,172 shares in the last quarter. Viking Global Investors LP boosted its stake in Walgreens Boots Alliance by 562.8% in the fourth quarter. Viking Global Investors LP now owns 7,899,951 shares of the pharmacy operator’s stock valued at $653,800,000 after buying an additional 6,708,040 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its stake in Walgreens Boots Alliance by 138.3% in the third quarter. Lazard Asset Management LLC now owns 7,680,077 shares of the pharmacy operator’s stock valued at $619,166,000 after buying an additional 4,457,421 shares in the last quarter. Hedge funds and other institutional investors own 59.98% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ:WBA) traded down 0.13% during mid-day trading on Friday, hitting $84.03. The stock had a trading volume of 3,698,774 shares. Walgreens Boots Alliance Inc has a one year low of $75.74 and a one year high of $88.00. The company has a 50 day moving average price of $83.93 and a 200 day moving average price of $83.21. The stock has a market cap of $90.83 billion, a P/E ratio of 21.60 and a beta of 1.20.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 EPS for the quarter, meeting the consensus estimate of $1.36. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The company had revenue of $29.45 billion for the quarter, compared to analyst estimates of $30.17 billion. During the same quarter last year, the business earned $1.31 earnings per share. Walgreens Boots Alliance’s revenue was down 2.4% compared to the same quarter last year. On average, equities analysts anticipate that Walgreens Boots Alliance Inc will post $4.98 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, June 12th. Shareholders of record on Thursday, May 18th will be paid a $0.375 dividend. The ex-dividend date is Tuesday, May 16th. This represents a $1.50 annualized dividend and a dividend yield of 1.79%. Walgreens Boots Alliance’s payout ratio is currently 39.68%.
TRADEMARK VIOLATION NOTICE: “Bridges Investment Counsel Inc. Cuts Stake in Walgreens Boots Alliance Inc (WBA)” was originally published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.com-unik.info/2017/04/21/bridges-investment-counsel-inc-has-373000-position-in-walgreens-boots-alliance-inc-wba-updated.html.
Several research analysts recently weighed in on WBA shares. Evercore ISI reiterated a “buy” rating and issued a $93.00 price objective on shares of Walgreens Boots Alliance in a research report on Tuesday, January 31st. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a research report on Tuesday, January 17th. Atlantic Securities upgraded Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 price objective for the company in a research report on Monday, February 6th. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Friday, January 6th. Finally, Robert W. Baird reiterated an “outperform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, January 24th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and eleven have given a buy rating to the stock. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus target price of $91.77.
In other news, Director Janice M. Babiak purchased 600 shares of the company’s stock in a transaction on Thursday, February 2nd. The shares were bought at an average price of $80.68 per share, for a total transaction of $48,408.00. Following the completion of the purchase, the director now owns 600 shares of the company’s stock, valued at $48,408. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, COO Ornella Barra purchased 124,000 shares of the company’s stock in a transaction on Tuesday, February 7th. The stock was purchased at an average price of $80.93 per share, for a total transaction of $10,035,320.00. Following the purchase, the chief operating officer now directly owns 1,690,336 shares of the company’s stock, valued at approximately $136,798,892.48. The disclosure for this purchase can be found here. 13.50% of the stock is currently owned by company insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
What are top analysts saying about Walgreens Boots Alliance Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc and related companies.